Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer

A Giudice1, M Montella1, M Boccellino2

  • 1Epidemiology Unit, National Cancer Institute of Naples "G. Pascale Foundation", IRCCS, 80131 Naples, Italy.

Current Molecular Medicine
|December 20, 2017
PubMed

Insights

Green tea catechins, like EGCG, show promise in treating prostate cancer by reversing epigenetic changes and modulating miRNA expression. These natural compounds may enhance chemotherapy effectiveness and reduce side effects.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Prostate cancer, particularly castrate-resistant (CRPC), presents significant treatment challenges.
  • Epigenetic modifications, including DNA methylation, histone modifications, and microRNAs (miRNAs), are crucial in prostate cancer development and progression.
  • miRNAs are small non-coding RNAs that regulate gene expression, impacting cancer pathways.

Purpose of the Study:

  • To review the role of green tea catechins in modulating epigenetic alterations and miRNA expression in prostate cancer.
  • To explore the potential of green tea catechins, such as epigallocatechin gallate (EGCG), as chemopreventive and therapeutic agents.
  • To summarize evidence on the synergistic effects of green tea polyphenols (GTPs) with conventional chemotherapeutics.

Main Methods:

  • Literature review of recent studies on green tea catechins, epigenetics, and prostate cancer.
  • Analysis of research investigating EGCG's effects on DNA methylation, histone modifications, and miRNA expression.
  • Examination of studies on the combined use of GTPs and chemotherapeutic agents.

Main Results:

  • Green tea catechins, particularly EGCG, demonstrate epigenetic modulatory effects, including influencing DNA methylation and histone modifications.
  • EGCG impacts miRNA expression and targets messenger RNAs (mRNAs), contributing to the inhibition of prostate cancer cell growth.
  • Green tea polyphenols exhibit synergistic effects when combined with standard cancer chemotherapeutics, potentially reducing toxicity.

Conclusions:

  • Green tea catechins represent a promising natural strategy for prostate cancer chemoprevention and therapy due to their epigenetic and miRNA-modulating activities.
  • Combining green tea catechins with existing chemotherapeutics may enhance treatment efficacy while mitigating adverse side effects.
  • Further research into EGCG and other GTPs could lead to novel therapeutic combinations for managing prostate cancer, especially CRPC.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
15
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.9K